SAVE Our Poultry Act
Summary
The SAVE Our Poultry Act (HR2868) is an early-stage bill that designates HPAI research as a high-priority USDA grant area, but authorizes no specific funding. It remains referred to the House Agriculture Committee with no further action since introduction on April 10, 2025, and carries no direct or material market implications for publicly traded companies at this time.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR2868 is a procedural authorization bill with no funding attached — it only lists HPAI as a USDA research priority area.
- 2.Zero legislative activity since introduction on April 10, 2025 — low probability of passage in the 119th Congress.
- 3.No publicly traded companies are directly named, and the grant mechanism (land-grant universities) does not create corporate revenue streams.
Market Implications
No market implications at this stage. The bill does not authorize spending, create tax credits, impose mandates, or establish procurement programs. Poultry sector equities (TSN, PPC) are not affected. Poultry vaccine developers (e.g., privately held or academic) are not publicly traded. Investors should ignore this bill until and unless it receives a markup, a funding appropriation, or a Senate companion bill.
Full Analysis
This bill amends the Food, Agriculture, Conservation, and Trade Act of 1990 to list highly pathogenic avian influenza (HPAI) as a high-priority research and extension area. It does not appropriate any funds or direct any specific spending — it merely authorizes USDA to award grants to land-grant colleges and universities for vaccine development and biosecurity research. No dollar amount is specified, meaning any future funding would require a separate appropriations process.
The bill was introduced by Rep. Sarah McBride (D-DE), a junior House member, with four cosponsors. It has been referred to the House Committee on Agriculture and has seen zero legislative action since its introduction. No companion bill exists in the Senate. This is a procedural authorization bill with very low legislative velocity and no clear path to passage in the current Congress.
No publicly traded poultry producers, vaccine developers, or biosecurity companies are directly named or materially affected by this bill at this stage. Even if enacted, the mechanism (grant-making via land-grant universities) would not create a direct revenue stream for publicly traded companies. The most exposed publicly traded poultry processors — such as Tyson Foods (TSN), Pilgrim's Pride (PPC), and Sanderson Farms (now part of Cargill, privately held) — are not beneficiaries of university research grants.
Given that this is an authorization-only bill with no funding, no appropriation, no legislative momentum, and no direct corporate beneficiaries, the market impact is effectively zero. Investors should monitor for a companion Senate bill, committee hearings, or an associated appropriations measure before assigning any market relevance.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Providing Meaningful Water Quality Improvements Through Collaboration and Oversight of Federal Support
This executive order revokes Executive Order 13508, which had mandated Chesapeake Bay restoration efforts, and directs federal agencies to prioritize funding for direct, on-the-ground water quality projects. It also instructs the EPA to work with states to assess and encourage the repeal of stormwater management fees (rain taxes) that have burdened residents, aiming to reduce costs while maintaining environmental progress.
Excluding Certain Canadian Alcoholic Beverages from Importation into the United States in Response to Continued Discrimination Against the Commerce of the United States with Respect to Alcoholic Beverages
President Trump, invoking Section 338 of the Tariff Act of 1930, orders an import ban on certain Canadian alcoholic beverages effective September 29, 2026, escalating previous 50% ad valorem duties. This action targets Canadian discrimination against U.S. alcoholic beverages, citing Canada's broken commitments and additional retaliation. The ban replaces the tariff for specified products with a complete exclusion from entry into the United States.
Modifying the Scope of Products of Canada Subject to the Additional Duties Imposed to Offset Canadian Discrimination Against the Commerce of the United States with Respect to Alcoholic Beverages
This proclamation modifies the list of Canadian products subject to a 50% ad valorem additional duty originally imposed under Proclamation 11046, effective September 15, 2026. It adds certain products to the duty (Annex I, Part A) and removes others (Annex I, Part B), based on recommendations from senior executive branch officials to better serve the public interest while still offsetting Canadian discrimination against U.S. alcoholic beverages. The action directs U.S. Customs and Border Protection to implement the changes and maintains that the duties are in addition to any existing section 232 duties.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →